The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.70
Bid: 32.00
Ask: 33.40
Change: -0.40 (-1.21%)
Spread: 1.40 (4.375%)
Open: 33.10
High: 33.20
Low: 32.70
Prev. Close: 33.10
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Matt Mead joins as Chief Investment Officer

26 May 2015 07:01

RNS Number : 0412O
Mercia Technologies PLC
26 May 2015
 



26 May 2015

 

Mercia Technologies PLC

 

Matt Mead joins as Chief Investment Officer of Mercia Technologies

 

Further to the announcement on 25 March 2015, Matt Mead has today taken up the role of Chief Investment Officer of Mercia Technologies PLC ("Mercia") and a Director of the Company.

 

In accordance with the FCA Disclosure and Transparency Rule 3.1.2 R, Matt notified Mercia on appointment that he holds 43,121 ordinary shares of 0.001p each (0.02%) in the capital of the company.

 

There are no other matters requiring disclosure under the AIM Rules.

 

Enquiries:

 

Mercia Technologies PLC (www.merciatechnologies.com)

+44 (0) 330 223 1430

Mark Payton, Chief Executive

Martin Glanfield, Chief Financial Officer

Cenkos Securities

+44 (0) 20 7397 8900

Ivonne Cantu (Nomad) / Mark Connelly

Instinctif Partners

+44 (0) 20 7457 2020

Kay Larsen / Chantal Woolcock

 

 

Note to editors

 

Mercia Technologies PLC

Mercia creates, funds and develops technology businesses nationally with an emphasis in the Midlands, the North and Scotland. It brings technology transfer, company formation, incubation, commercialisation and investment to technology ventures. Approximately 50% of its investments derive from university spinouts. Mercia invests across key technology sectors in which it has deep sector expertise.

 

The Mercia model is one of patiently nurturing businesses through its third party funds under management, and then scaling them with direct investment at the point of commercial delivery. Through this, Mercia has a well seeded portfolio and pipeline of investments - its 'emerging stars'. The Group has a direct investment in 15 operating companies and access to a portfolio of 44 businesses through its third party funds, managed by its wholly owned subsidiary Mercia Fund Management.

 

Mercia's shares started trading on AIM on 18 December 2014. Since then Mercia has invested approximately £13m directly across its portfolio of emerging stars, which in themselves have attracted a total investment of over £70m alongside investment from the Group to date. In addition to its direct investments, Mercia (via Mercia Fund Management) has invested over £19m to build its portfolio of potential emerging stars.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPKBDPCBKKAPB
Date   Source Headline
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM
24th Sep 20207:00 amRNSAGM Statement
18th Sep 20207:00 amRNSLife Sciences’ Portfolio Update
24th Aug 20207:00 amRNSGrant of Options
31st Jul 20207:03 amRNSPublication of Annual Report
29th Jul 20202:31 pmRNSDirector/PDMR Dealings
14th Jul 20207:00 amRNSPreliminary results
9th Jul 20207:00 amRNSSale of The Native Antigen Company
1st Jul 20207:00 amRNSPortfolio company MIP Diagnostics raises £5.1m
11th Jun 20207:00 amRNSNotice of Results
27th May 202011:08 amRNSMercia accredited by BBB under CBILS
14th May 20207:00 amRNSMedherant partners with Cycle Pharmaceuticals
6th May 20207:00 amRNSInvestment into OXGENE
21st Apr 20207:00 amRNSBritish Business Bank increases Mercia’s mandate
3rd Apr 202012:47 pmRNSNVM VCTs raise £38.2 million
2nd Apr 20207:00 amRNSPortfolio companies collaborate against COVID-19
27th Mar 202011:30 amRNSDirector/PDMR Dealings
25th Mar 20203:08 pmRNSCOVID-19 Business Update
25th Mar 20201:42 pmRNSNotification of Major Holdings
18th Mar 202010:59 amRNSNOTIFICATION OF MAJOR HOLDINGS
11th Mar 20204:18 pmRNSNOTIFICATION OF MAJOR HOLDINGS
4th Feb 20203:20 pmRNSNOTIFICATION OF MAJOR HOLDINGS
4th Feb 20203:20 pmRNSPDMR / Director Dealings
4th Feb 20208:50 amRNSNotification of Major Holdings
4th Feb 20207:00 amRNSHolding in Company
29th Jan 20207:00 amRNSGrant of Options
22nd Jan 202012:49 pmRNSForm 8.3 - RedX Pharma PLC
17th Jan 20204:45 pmRNSNotification of Major Holdings
16th Jan 20207:00 amRNSnDreams makes continuing commercial progress
9th Jan 20202:06 pmRNSNOTIFICATION OF MAJOR HOLDINGS
9th Jan 20202:00 pmRNSNOTIFICATION OF MAJOR HOLDINGS
31st Dec 201910:55 amRNSNotification of Major Holdings
30th Dec 201911:57 amRNSNOTIFICATION OF MAJOR HOLDINGS
30th Dec 201911:36 amRNSNOTIFICATION OF MAJOR HOLDINGS
27th Dec 201912:01 pmRNSNOTIFICATION OF MAJOR HOLDINGS
24th Dec 201912:16 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20193:36 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20192:14 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20192:04 pmRNSCompletion of Acquisition
23rd Dec 201912:44 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20199:49 amRNSDirector/PDMR Dealings
20th Dec 201910:29 amRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.